Ligand Pharmaceuticals Inc (LGND)

Financing Cash Flow

$546.43M

Quarterly · Period ending: · USD

LGND logo

LGND Financing Cash Flow

Latest reported$546.43M
LGND Quarterly Cash from Financing (-$200.00K → $546.43M)
High-resolution chart · PNG

LGND financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
546,434,000
-14,133,000
8,330,000
409,645,000
14,997,000
-4,676,000
20,388,000
55,080,000
9,491,000
12,223,000
6,264,000
3,270,000
-67,757,000
-775,000
-5,298,000
-40,829,000
-59,442,000
-170,421,000
4,163,999
-385,000
-49,905,000
-91,635,000
-27,529,000
-3,706,000
-5,000
-279,305,000
-83,693,000
-211,312,000
-37,591,000
-152,576,000
-347,085,000
58,917,000
613,529,000
3,224,000
-7,255,000
1,404,000
-5,000
-1,667,000
-2,094,000
1,629,000
1,469,000
511,000
1,470,000
1,460,000
4,649,000
781,000
-28,995,000
162,319,000
-3,058,000
-241,000
-2,663,000
-2,048,000
-2,359,000
-9,388,000
3,235,000
1,439,000
82,000
-840,000
52,000
2,000
5,000,000
24,945,000
-178,000
-41,000
52,000
8,000
87,000
-100,000
-90,000
-3,585,000
-201,000
-331,000
-385,000
-2,093,000
-4,581,000
-10,430,000
-277,263,000
-35,425,000
32,695,000
179,000
386,000
41,000
-24,000
-842,000
-153,000
818,000
-4,589,000
2,280,000
6,477,000
3,747,000
4,619,000
48,294,000
4,342,000
-16,303,000
131,085,000
1,958,000
17,477,000
1,519,000
2,177,000
903,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.